These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31360179)

  • 1. Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement.
    Beiert T; Straesser S; Malotki R; Stöckigt F; Schrickel JW; Andrié RP
    Arch Med Sci; 2019 Jul; 15(4):845-856. PubMed ID: 31360179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachycardia Therapy Outcomes of Ischemic Versus Nonischemic Cardiomyopathy on Cardiac Resynchronization Therapy: A Propensity Score-matched Analysis.
    Malik J; Awais M; Shabbir M; Rauf A; Zaffar S; Hayat A; Mehmoodi A
    J Community Hosp Intern Med Perspect; 2023; 13(6):83-89. PubMed ID: 38596550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.
    Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S;
    J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study.
    Fang CY; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC; Lee WC
    PeerJ; 2018; 6():e5312. PubMed ID: 30038875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up.
    Rosenkaimer SL; El-Battrawy I; Dreher TC; Gerhards S; Röger S; Kuschyk J; Borggrefe M; Akin I
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32214048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is CRT pro-arrhythmic? A comparative analysis of the occurrence of ventricular arrhythmias between patients implanted with CRTs and ICDs.
    Gopalamurugan AB; Ganesha Babu G; Rogers DP; Simpson AL; Ahsan SY; Lambiase PD; Chow AW; Lowe MD; Rowland E; Segal OR
    Front Physiol; 2014; 5():334. PubMed ID: 25278901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid-rate nonsustained ventricular tachycardias in high-risk dilated cardiomyopathy patients.
    Lee WC; Watanabe M; Yokoshiki H; Temma T; Kamada R; Takahashi M; Hagiwara H; Takahashi Y; Anzai T
    Pacing Clin Electrophysiol; 2020 Oct; 43(10):1086-1095. PubMed ID: 32735041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.
    Wasmer K; Köbe J; Andresen D; Zahn R; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Martens E; Hochadel M; Senges J; Klein H; Eckardt L
    Clin Res Cardiol; 2013 Jul; 102(7):513-21. PubMed ID: 23543113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Herrmann T; Kuschyk J; Lang S; Doesch C; Papavassiliu T; Streitner I; Veltmann C; Haghi D; Borggrefe M
    PLoS One; 2013; 8(5):e63911. PubMed ID: 23675514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy.
    Loughlin G; Avila P; Martinez-Ferrer JB; Alzueta J; Vinolas X; Brugada J; Arizon JM; Fernandez-Lozano I; García-Campo E; Basterra N; Fernandez De La Concha J; Arenal A
    Europace; 2017 Nov; 19(11):1818-1825. PubMed ID: 28339565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure.
    Franke J; Zugck C; Hochadel M; Hack A; Frankenstein L; Zhao JD; Ehlermann P; Nelles M; Zeymer U; Winkler R; Zahn R; Katus HA; Senges J
    Int J Cardiol Heart Vasc; 2015 Jun; 7():61-68. PubMed ID: 28785647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Cardiac Arrhythmias in Patients With Anthracycline-Related Cardiomyopathy.
    Mazur M; Wang F; Hodge DO; Siontis BL; Beinborn DS; Villarraga HR; Lerman A; Friedman PA; Herrmann J
    JACC Clin Electrophysiol; 2017 Feb; 3(2):139-150. PubMed ID: 29759386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.
    Karaoguz R; Maydanozcu S; Altun T; Güldal M; Akyürek O; Erol C
    Int Heart J; 2006 Sep; 47(5):763-73. PubMed ID: 17106147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
    Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
    Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.